FDA-Drug2026-10-14Class IIPROCESSING DEFECT

Carolina Infusion QUAD-MIX injectable recalled for sterility assurance issue

OTHERNationwide distributionDrugs

What this means

Carolina Infusion, LLC is recalling QUAD-MIX injectable medication (a compounded injection containing papaverine, phentolamine, alprostadil, and tropicamide) due to concerns about sterility. The issue stems from processing equipment used to prepare the product. The affected lot is 08032026@24, with a Beyond Use Date of 09/17/2026.

  • If you have received this medication, contact your healthcare provider immediately.
  • Do not use the product if you have it.
  • Return the medication to the pharmacy or prescriber for safe disposal.
  • Ask your provider about alternative treatment options.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Lack of Assurance of Sterility: Related to processing equipment used in compounded product.

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
5 mls in patient specific syringe doses
Manufactured in
95 Bees Creek Rd, N/A, Ridgeland, SC, United States
Products
QUAD-MIX( PAPAV/PHENTO/ALPROS/TROP) INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0021-2027

More Carolina Infusion recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.